Reuters logo
BRIEF-Shilpa Medicare gets USFDA approval for Azacitidine injection
October 4, 2016 / 5:51 AM / in a year

BRIEF-Shilpa Medicare gets USFDA approval for Azacitidine injection

Oct 4 (Reuters) - Shilpa Medicare Ltd

* Received an approval from the United States Food & Drug Administration for Azacitidine - Injection Anda of SEZ formulations facility situated at Jadcherla Source text: bit.ly/2doO3Sd Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below